Guselkumab Adds PsA Structural Damage Inhibition to Label

Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/guselkumab-adds-psoriatic-arthritis-structural-damage-2026a1000i12?src=rss

Author :

Publish date : 2026-05-29 17:39:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Guselkumab Adds PsA Structural Damage Inhibition to Label

Reassuring Data for Two High-Efficacy MS Meds in Pregnancy

Here’s Everything Wrong With the Offshore Ebola Quarantine Plan

Related Posts

Finding the Mystery to Trigger-Induced Atrial Fibrillation

Screening for Diabetes at Urgent Care Could Save Lives

ED Palliative Care Consultations Surge in Cancer Care

Is your period worsening your ADHD symptoms?

ADHD and periods: Are my hormones making my symptoms worse?

Lifestyle Changes May Slow Brain Aging in Adults Younger Than 70

Finding the Mystery to Trigger-Induced Atrial Fibrillation

Screening for Diabetes at Urgent Care Could Save Lives

ED Palliative Care Consultations Surge in Cancer Care

Is your period worsening your ADHD symptoms?

ADHD and periods: Are my hormones making my symptoms worse?

Lifestyle Changes May Slow Brain Aging in Adults Younger Than 70

Aspirin Alone Gets the Job Done for Clot Prevention After Joint Surgery

Study Probes Absolute Risk for ION With GLP-1 Agents

Categories

Archives